The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Swine Epidemic Diarrhea Vaccines Market Research Report 2025
Synopsis
Swine epidemic diarrhea virus (PEDV) is the causative agent of porcine epidemic diarrhea (PED), an acute and highly contagious enteric viral disease.
The global Swine Epidemic Diarrhea Vaccines market was valued at US$ 1354 million in 2023 and is anticipated to reach US$ 1907 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
The Animal Healthcare market is primarily driven by the increasing awareness about animal health and well-being, coupled with the rising prevalence of various animal diseases. Pet ownership has grown, leading to higher demand for veterinary services and products. Additionally, the growth of the livestock industry to meet global food demand further boosts the need for animal healthcare products. Advances in veterinary medicine and technology are also driving market growth, enabling better diagnosis, treatment, and preventive care for animals. However, challenges include regulatory complexities and the high cost of certain treatments, which can hinder accessibility for some pet owners or farmers. Striking a balance between quality care and affordability is crucial for the sustainable growth of the animal healthcare market.
This report aims to provide a comprehensive presentation of the global market for Swine Epidemic Diarrhea Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Epidemic Diarrhea Vaccines.
Report Scope
The Swine Epidemic Diarrhea Vaccines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Swine Epidemic Diarrhea Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Epidemic Diarrhea Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CAVAC
Green Cross Veterinary Products
Harrisvaccines, Inc.
Komipharm
Nisseiken
Qilu Animal Health
Zoetis
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Piglets
Adults Pigs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Swine Epidemic Diarrhea Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Swine epidemic diarrhea virus (PEDV) is the causative agent of porcine epidemic diarrhea (PED), an acute and highly contagious enteric viral disease.
The global Swine Epidemic Diarrhea Vaccines market was valued at US$ 1354 million in 2023 and is anticipated to reach US$ 1907 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
The Animal Healthcare market is primarily driven by the increasing awareness about animal health and well-being, coupled with the rising prevalence of various animal diseases. Pet ownership has grown, leading to higher demand for veterinary services and products. Additionally, the growth of the livestock industry to meet global food demand further boosts the need for animal healthcare products. Advances in veterinary medicine and technology are also driving market growth, enabling better diagnosis, treatment, and preventive care for animals. However, challenges include regulatory complexities and the high cost of certain treatments, which can hinder accessibility for some pet owners or farmers. Striking a balance between quality care and affordability is crucial for the sustainable growth of the animal healthcare market.
This report aims to provide a comprehensive presentation of the global market for Swine Epidemic Diarrhea Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Epidemic Diarrhea Vaccines.
Report Scope
The Swine Epidemic Diarrhea Vaccines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Swine Epidemic Diarrhea Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Epidemic Diarrhea Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CAVAC
Green Cross Veterinary Products
Harrisvaccines, Inc.
Komipharm
Nisseiken
Qilu Animal Health
Zoetis
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Piglets
Adults Pigs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Swine Epidemic Diarrhea Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Swine Epidemic Diarrhea Vaccines Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market by Application
1.3.1 Global Swine Epidemic Diarrhea Vaccines Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Piglets
1.3.3 Adults Pigs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Swine Epidemic Diarrhea Vaccines Market Perspective (2019-2030)
2.2 Swine Epidemic Diarrhea Vaccines Growth Trends by Region
2.2.1 Global Swine Epidemic Diarrhea Vaccines Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Swine Epidemic Diarrhea Vaccines Historic Market Size by Region (2019-2024)
2.2.3 Swine Epidemic Diarrhea Vaccines Forecasted Market Size by Region (2025-2030)
2.3 Swine Epidemic Diarrhea Vaccines Market Dynamics
2.3.1 Swine Epidemic Diarrhea Vaccines Industry Trends
2.3.2 Swine Epidemic Diarrhea Vaccines Market Drivers
2.3.3 Swine Epidemic Diarrhea Vaccines Market Challenges
2.3.4 Swine Epidemic Diarrhea Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Swine Epidemic Diarrhea Vaccines Players by Revenue
3.1.1 Global Top Swine Epidemic Diarrhea Vaccines Players by Revenue (2019-2024)
3.1.2 Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Players (2019-2024)
3.2 Global Swine Epidemic Diarrhea Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Swine Epidemic Diarrhea Vaccines Revenue
3.4 Global Swine Epidemic Diarrhea Vaccines Market Concentration Ratio
3.4.1 Global Swine Epidemic Diarrhea Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Swine Epidemic Diarrhea Vaccines Revenue in 2023
3.5 Swine Epidemic Diarrhea Vaccines Key Players Head office and Area Served
3.6 Key Players Swine Epidemic Diarrhea Vaccines Product Solution and Service
3.7 Date of Enter into Swine Epidemic Diarrhea Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Swine Epidemic Diarrhea Vaccines Breakdown Data by Type
4.1 Global Swine Epidemic Diarrhea Vaccines Historic Market Size by Type (2019-2024)
4.2 Global Swine Epidemic Diarrhea Vaccines Forecasted Market Size by Type (2025-2030)
5 Swine Epidemic Diarrhea Vaccines Breakdown Data by Application
5.1 Global Swine Epidemic Diarrhea Vaccines Historic Market Size by Application (2019-2024)
5.2 Global Swine Epidemic Diarrhea Vaccines Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Swine Epidemic Diarrhea Vaccines Market Size (2019-2030)
6.2 North America Swine Epidemic Diarrhea Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Swine Epidemic Diarrhea Vaccines Market Size by Country (2019-2024)
6.4 North America Swine Epidemic Diarrhea Vaccines Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Swine Epidemic Diarrhea Vaccines Market Size (2019-2030)
7.2 Europe Swine Epidemic Diarrhea Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Swine Epidemic Diarrhea Vaccines Market Size by Country (2019-2024)
7.4 Europe Swine Epidemic Diarrhea Vaccines Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size (2019-2030)
8.2 Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size by Region (2019-2024)
8.4 Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Swine Epidemic Diarrhea Vaccines Market Size (2019-2030)
9.2 Latin America Swine Epidemic Diarrhea Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Swine Epidemic Diarrhea Vaccines Market Size by Country (2019-2024)
9.4 Latin America Swine Epidemic Diarrhea Vaccines Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Size (2019-2030)
10.2 Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Size by Country (2019-2024)
10.4 Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CAVAC
11.1.1 CAVAC Company Detail
11.1.2 CAVAC Business Overview
11.1.3 CAVAC Swine Epidemic Diarrhea Vaccines Introduction
11.1.4 CAVAC Revenue in Swine Epidemic Diarrhea Vaccines Business (2019-2024)
11.1.5 CAVAC Recent Development
11.2 Green Cross Veterinary Products
11.2.1 Green Cross Veterinary Products Company Detail
11.2.2 Green Cross Veterinary Products Business Overview
11.2.3 Green Cross Veterinary Products Swine Epidemic Diarrhea Vaccines Introduction
11.2.4 Green Cross Veterinary Products Revenue in Swine Epidemic Diarrhea Vaccines Business (2019-2024)
11.2.5 Green Cross Veterinary Products Recent Development
11.3 Harrisvaccines, Inc.
11.3.1 Harrisvaccines, Inc. Company Detail
11.3.2 Harrisvaccines, Inc. Business Overview
11.3.3 Harrisvaccines, Inc. Swine Epidemic Diarrhea Vaccines Introduction
11.3.4 Harrisvaccines, Inc. Revenue in Swine Epidemic Diarrhea Vaccines Business (2019-2024)
11.3.5 Harrisvaccines, Inc. Recent Development
11.4 Komipharm
11.4.1 Komipharm Company Detail
11.4.2 Komipharm Business Overview
11.4.3 Komipharm Swine Epidemic Diarrhea Vaccines Introduction
11.4.4 Komipharm Revenue in Swine Epidemic Diarrhea Vaccines Business (2019-2024)
11.4.5 Komipharm Recent Development
11.5 Nisseiken
11.5.1 Nisseiken Company Detail
11.5.2 Nisseiken Business Overview
11.5.3 Nisseiken Swine Epidemic Diarrhea Vaccines Introduction
11.5.4 Nisseiken Revenue in Swine Epidemic Diarrhea Vaccines Business (2019-2024)
11.5.5 Nisseiken Recent Development
11.6 Qilu Animal Health
11.6.1 Qilu Animal Health Company Detail
11.6.2 Qilu Animal Health Business Overview
11.6.3 Qilu Animal Health Swine Epidemic Diarrhea Vaccines Introduction
11.6.4 Qilu Animal Health Revenue in Swine Epidemic Diarrhea Vaccines Business (2019-2024)
11.6.5 Qilu Animal Health Recent Development
11.7 Zoetis
11.7.1 Zoetis Company Detail
11.7.2 Zoetis Business Overview
11.7.3 Zoetis Swine Epidemic Diarrhea Vaccines Introduction
11.7.4 Zoetis Revenue in Swine Epidemic Diarrhea Vaccines Business (2019-2024)
11.7.5 Zoetis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Swine Epidemic Diarrhea Vaccines Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Live Vaccines
Table 3. Key Players of Killed Vaccines
Table 4. Global Swine Epidemic Diarrhea Vaccines Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Swine Epidemic Diarrhea Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Swine Epidemic Diarrhea Vaccines Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Swine Epidemic Diarrhea Vaccines Market Share by Region (2019-2024)
Table 8. Global Swine Epidemic Diarrhea Vaccines Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Swine Epidemic Diarrhea Vaccines Market Share by Region (2025-2030)
Table 10. Swine Epidemic Diarrhea Vaccines Market Trends
Table 11. Swine Epidemic Diarrhea Vaccines Market Drivers
Table 12. Swine Epidemic Diarrhea Vaccines Market Challenges
Table 13. Swine Epidemic Diarrhea Vaccines Market Restraints
Table 14. Global Swine Epidemic Diarrhea Vaccines Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Swine Epidemic Diarrhea Vaccines Market Share by Players (2019-2024)
Table 16. Global Top Swine Epidemic Diarrhea Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Epidemic Diarrhea Vaccines as of 2023)
Table 17. Ranking of Global Top Swine Epidemic Diarrhea Vaccines Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Swine Epidemic Diarrhea Vaccines Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Swine Epidemic Diarrhea Vaccines Product Solution and Service
Table 21. Date of Enter into Swine Epidemic Diarrhea Vaccines Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Swine Epidemic Diarrhea Vaccines Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Type (2019-2024)
Table 25. Global Swine Epidemic Diarrhea Vaccines Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Type (2025-2030)
Table 27. Global Swine Epidemic Diarrhea Vaccines Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Application (2019-2024)
Table 29. Global Swine Epidemic Diarrhea Vaccines Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Application (2025-2030)
Table 31. North America Swine Epidemic Diarrhea Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Swine Epidemic Diarrhea Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Swine Epidemic Diarrhea Vaccines Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Swine Epidemic Diarrhea Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Swine Epidemic Diarrhea Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Swine Epidemic Diarrhea Vaccines Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Swine Epidemic Diarrhea Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Swine Epidemic Diarrhea Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Swine Epidemic Diarrhea Vaccines Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Size by Country (2025-2030) & (US$ Million)
Table 46. CAVAC Company Detail
Table 47. CAVAC Business Overview
Table 48. CAVAC Swine Epidemic Diarrhea Vaccines Product
Table 49. CAVAC Revenue in Swine Epidemic Diarrhea Vaccines Business (2019-2024) & (US$ Million)
Table 50. CAVAC Recent Development
Table 51. Green Cross Veterinary Products Company Detail
Table 52. Green Cross Veterinary Products Business Overview
Table 53. Green Cross Veterinary Products Swine Epidemic Diarrhea Vaccines Product
Table 54. Green Cross Veterinary Products Revenue in Swine Epidemic Diarrhea Vaccines Business (2019-2024) & (US$ Million)
Table 55. Green Cross Veterinary Products Recent Development
Table 56. Harrisvaccines, Inc. Company Detail
Table 57. Harrisvaccines, Inc. Business Overview
Table 58. Harrisvaccines, Inc. Swine Epidemic Diarrhea Vaccines Product
Table 59. Harrisvaccines, Inc. Revenue in Swine Epidemic Diarrhea Vaccines Business (2019-2024) & (US$ Million)
Table 60. Harrisvaccines, Inc. Recent Development
Table 61. Komipharm Company Detail
Table 62. Komipharm Business Overview
Table 63. Komipharm Swine Epidemic Diarrhea Vaccines Product
Table 64. Komipharm Revenue in Swine Epidemic Diarrhea Vaccines Business (2019-2024) & (US$ Million)
Table 65. Komipharm Recent Development
Table 66. Nisseiken Company Detail
Table 67. Nisseiken Business Overview
Table 68. Nisseiken Swine Epidemic Diarrhea Vaccines Product
Table 69. Nisseiken Revenue in Swine Epidemic Diarrhea Vaccines Business (2019-2024) & (US$ Million)
Table 70. Nisseiken Recent Development
Table 71. Qilu Animal Health Company Detail
Table 72. Qilu Animal Health Business Overview
Table 73. Qilu Animal Health Swine Epidemic Diarrhea Vaccines Product
Table 74. Qilu Animal Health Revenue in Swine Epidemic Diarrhea Vaccines Business (2019-2024) & (US$ Million)
Table 75. Qilu Animal Health Recent Development
Table 76. Zoetis Company Detail
Table 77. Zoetis Business Overview
Table 78. Zoetis Swine Epidemic Diarrhea Vaccines Product
Table 79. Zoetis Revenue in Swine Epidemic Diarrhea Vaccines Business (2019-2024) & (US$ Million)
Table 80. Zoetis Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Swine Epidemic Diarrhea Vaccines Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Swine Epidemic Diarrhea Vaccines Market Share by Type: 2023 VS 2030
Figure 3. Live Vaccines Features
Figure 4. Killed Vaccines Features
Figure 5. Global Swine Epidemic Diarrhea Vaccines Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Swine Epidemic Diarrhea Vaccines Market Share by Application: 2023 VS 2030
Figure 7. Piglets Case Studies
Figure 8. Adults Pigs Case Studies
Figure 9. Swine Epidemic Diarrhea Vaccines Report Years Considered
Figure 10. Global Swine Epidemic Diarrhea Vaccines Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Swine Epidemic Diarrhea Vaccines Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Swine Epidemic Diarrhea Vaccines Market Share by Region: 2023 VS 2030
Figure 13. Global Swine Epidemic Diarrhea Vaccines Market Share by Players in 2023
Figure 14. Global Top Swine Epidemic Diarrhea Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Epidemic Diarrhea Vaccines as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Swine Epidemic Diarrhea Vaccines Revenue in 2023
Figure 16. North America Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Swine Epidemic Diarrhea Vaccines Market Share by Country (2019-2030)
Figure 18. United States Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Swine Epidemic Diarrhea Vaccines Market Share by Country (2019-2030)
Figure 22. Germany Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Share by Region (2019-2030)
Figure 30. China Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Swine Epidemic Diarrhea Vaccines Market Share by Country (2019-2030)
Figure 38. Mexico Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Share by Country (2019-2030)
Figure 42. Turkey Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. CAVAC Revenue Growth Rate in Swine Epidemic Diarrhea Vaccines Business (2019-2024)
Figure 45. Green Cross Veterinary Products Revenue Growth Rate in Swine Epidemic Diarrhea Vaccines Business (2019-2024)
Figure 46. Harrisvaccines, Inc. Revenue Growth Rate in Swine Epidemic Diarrhea Vaccines Business (2019-2024)
Figure 47. Komipharm Revenue Growth Rate in Swine Epidemic Diarrhea Vaccines Business (2019-2024)
Figure 48. Nisseiken Revenue Growth Rate in Swine Epidemic Diarrhea Vaccines Business (2019-2024)
Figure 49. Qilu Animal Health Revenue Growth Rate in Swine Epidemic Diarrhea Vaccines Business (2019-2024)
Figure 50. Zoetis Revenue Growth Rate in Swine Epidemic Diarrhea Vaccines Business (2019-2024)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
